Anuh Pharma Limited has informed the Exchange about General Updates under Regulation 30 for re-appointment of Internal Auditor
ANUHPHR · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Anuh Pharma's Board of Directors, based on the Audit Committee's recommendation, has approved the re-appointment of M/s. SBU & Co., Chartered Accountants (Firm Registration No.: 147522W/W101053) as the Internal Auditor of the Company for the financial year 2025-26. The decision was taken at the Board meeting held on May 23, 2025. SBU & Co. LLP is a Mumbai-based Chartered Accountancy firm established in July 2018, offering audit, compliance, assurance, and advisory services across sectors including healthcare and manufacturing. The disclosure is being made under Regulation 30 of the SEBI Listing Regulations, 2015.
This is a routine governance disclosure and is unlikely to have any material impact on the stock price or shareholder interests. It confirms continuity in the company's internal audit function for the coming financial year.